ATP (Apple Tree Partners)
Status
ACTIVE
Global HQ
Chicago, United States
Countries of investment
- Australia
- New Zealand
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
- Series C
Industries
- Fintech
- AI
- Health Tech
- Blockchain
- Crypto
About
ATP, Founded in 1999, is a life sciences venture Capital firm with $2.9 billion in committed Capital. They have offices in New York, South San Francisco, and Cambridge, MA. ATP specializes in translating emerging scientific advances into innovative treatments and creating companies at various stages of development.
ATP, Founded in 1999, is a life sciences venture Capital firm with $2.9 billion in committed Capital. They have offices in New York, South San Francisco, and Cambridge, MA. ATP specializes in translating emerging scientific advances into innovative treatments and creating companies at various stages of development.
Investment Thesis
ATP focuses on creating and investing in transformative BioTech companies. They provide flexible Capital, strategic insight, and operational resources to build Sustainable, researchdriven enterprises. ATP invests in companies from preIP ideas to asset spinouts and supports them from seed stage through IPO and beyond.
Portfolio
Aulos Bioscience
Braeburn
Chinook Therapeutics
Coelacanth
Corvidia Therapeutics
Cyrano Sciences
Deep Apple Therapeutics
Evercrisp Biosciences
Galvanize Therapeutics
Gloucester Pharma
HeartWare International
Initial Therapeutics
Marengo Therapeutics
Marlinspike Therapeutics
Nereid Therapeutics